Volume 96, issue 10, octobre 2009

Synthèse

Involvement of human papillomavirus in upper aero-digestive tracts cancers (p.941-50)
P Ernoux NeufCoeur, M Arafa, P Delvenne, S Saussez

Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting (p.951-60)
J-P Durand, I Madelaine, F Scotté

Access to preventative care, screening and treatment of women in vulnerable socio-economic groups presenting with cervical cancer (p.961-9)
C Dalmon, E Guillot, A Rodrigues, K Alves, P Madelenat, D Mahieu-Caputo, M Uzan, F Reyal

Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel (p.971-7)
L Simon, M-C Halilou, L Gladieff, M Gadiou, F Herin, I Hennebelle, É Chatelut, G Ferron

Estimation of individual breast cancer risk: relevance and limits of risk estimation models (p.979-88)
A De Pauw, D Stoppa-Lyonnet, N Andrieu, B Asselain

Basaloid squamous cell carcinomas of the head and neck (p.989-1004)
J Thariat, C Badoual, C Faure, E de Mones, C Butori, J Santini, G Poissonnet, P Maingon, S Faivre, J Klijanienko, J Lacau Saint-Guily, CA Righini

Impact of radiotherapy on fertility in female patients (p.1005-11)
C Chargari, P Castadot, N Gillion, O Bauduceau, L Védrine, C Haie-Meder, J-P Spano, N Magné

Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy (p.1013-28)
E Bardet, J Bourhis, L Cals, J Fayette, J Guigay, S Hans, J Lacau Saint-Guily, F Lagarde, B Lallemant, G Milano, F Rolland, J-L Lefebvre

Electronic journal of oncology

XRCC1 codon 280 and ERCC2 codon 751 polymorphisms and risk of esophageal squamous cell carcinoma in a Chinese population (p.10061-5)
Xian-Dun Zhai, Yao-Nan Mo, Xiao-Qi Xue, Gui-Sen Zhao, Lin-Bo Gao, Hong-Wei Ai, Yi Ye

Tribune libre

Sur l’enseignement de la cancérologie (p.919-21)
Bernard Hœrni

Article original

Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status (p.923-8)
Y Bensouda, F André, T Boulet, A Al-Ghuzlan, R Conforti, F Troalen, C Bourgier, H Errihani, M Spielmann, S Delaloge

Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region (p.929-40)
B Trombert Paviot, T Bachelot, G Clavreul, J-P Jacquin, D Mille, J-M Rodrigues